Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Recombinant Adeno-associated virus vectors (rAAV) are widely used for gene delivery and multiple naturally occurring serotypes have been harnessed to target cells in different tissues and organs including the brain. Here, we provide a detailed and quantitative analysis of the transduction profiles of rAAV vectors based on six of the most commonly used serotypes (AAV1, AAV2, AAV5, AAV6, AAV8, AAV9) that allows systematic comparison and selection of the optimal vector for a specific application. In our studies we observed marked differences among serotypes in the efficiency to transduce three different brain regions namely the striatum, hippocampus and neocortex of the mouse. Despite the fact that the analyzed serotypes have the general ability to transduce all major cell types in the brain (neurons, microglia, astrocytes and oligodendrocytes), the expression level of a reporter gene driven from a ubiquitous promoter varies significantly for specific cell type / serotype combinations. For example, rAAV8 is particularly efficient to drive transgene expression in astrocytes while rAAV9 appears well suited for the transduction of cortical neurons. Interestingly, we demonstrate selective retrograde transport of rAAV5 along axons projecting from the ventral part of the entorhinal cortex to the dentate gyrus. Furthermore, we show that self-complementing rAAV can be used to significantly decrease the time required for the onset of transgene expression in the mouse brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“AAV5 transduces only granular cells”
From AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease (2018) · cites this paper as [69]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“AAV2 is restricted to pyramidal and granular cells”
From AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease (2018) · cites this paper as [69]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They express the transgene within days or weeks and can reach full expression levels after 4-6 weeks in vivo [20,21].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While the promoter was cytomegalovirus (CMV), AAV9 has robust tropism for neurons and displays high expression levels in the hippocampus (Aschauer et al., 2013).”
From Hippocampal TMEM55B overexpression in the 5XFAD mouse model of Alzheimer's disease (2024) · cites this paper as Aschauer et al., 2013
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Place navigation impaired in rats with hippocampal lesions
Morris, R. G. M., Garrud, P., Rawlins, J. N. P., & O'Keefe, J. (1982) · Nature · doi:10.1038/297681a0 · Cited by 6,340 · cited 1×
“We choose the hippocampus as this is an intensely studied brain region for its role in memory formation and spatial navigation [20], the striatum for its role in the coordination of movements and neurological diseases such as Parkinson’s disease [21,22] and finally the neocortex as the part of the brain specific to ma…”
Genome-wide atlas of gene expression in the adult mouse brain
Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A. F., Boguski, M. S., Brockway, K. S., Byrnes, E. J., et al. (2007) · Nature · doi:10.1038/nature05453 · Cited by 5,572 · cited 1×
“However, in situ expression data does not indicate selective expression of PDGFR alpha or beta in the entorhinal cortex that could explain specific retrograde labeling of entorhinal neurons in a simple manner [67].”
BackgroundInterneurons of the neocortical inhibitory system
Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., & Wu, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1519 · Cited by 2,954 · cited 1×
“We chose gamma-aminobutyric acid (GABA) as a marker for the major population of inhibitory neurons in the central brain [27], oligodendrocyte transcription factor 2 (Olig2) as a marker for oligodendrocytes [28], ionized calcium-binding adapter molecule 1 (Iba1) as a marker for microglia [29] and glial fibrillary acidi…”
MethodA resource of Cre driver lines for genetic targeting of GABAergic neurons in cerebral cortex
Taniguchi, H., He, M., Wu, P., Kim, S., Paik, R., Sugino, K., Kvitsani, D., Fu, Y., Lu, J., Lin, Y., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.07.026 · Cited by 1,828 · cited 2×
“To determine what population of long-range projecting neurons is selectively labeled by AAV5 we performed injections of rAAV5 in a transgenic mouse strain in which GABA-ergic interneurons are labeled by the red fluorescent reporter protein tdTomato [26,50].”
BackgroundMethodLearning and Memory Functions of the Basal Ganglia
Packard, M. G., & Knowlton, B. J. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142937 · Cited by 1,717 · cited 1×
“We choose the hippocampus as this is an intensely studied brain region for its role in memory formation and spatial navigation [20], the striatum for its role in the coordination of movements and neurological diseases such as Parkinson’s disease [21,22] and finally the neocortex as the part of the brain specific to ma…”
Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
Zincarelli, C., Soltys, S., Rengo, G., & Rabinowitz, J. E. (2008) · Molecular Therapy · doi:10.1038/mt.2008.76 · Cited by 1,490 · cited 3×
“Indeed, significant differences in transduction efficacy of various serotypes for particular tissues and cell types have been described [11,12,16-19].”
BackgroundAmygdala circuitry mediating reversible and bidirectional control of anxiety
Tye, K. M., Prakash, R., Kim, S.-Y., Fenno, L. E., Grosenick, L., Zarabi, H., Thompson, K. R., Gradinaru, V., Ramakrishnan, C., & Deisseroth, K. (2011) · Nature · doi:10.1038/nature09820 · Cited by 1,289 · cited 1×
“In recent years many studies have taken advantage of recombinant viral vectors derived from Adeno-associated virus (AAV) as a gene delivery tool [3-5].”
BackgroundInduction of neurogenesis in the neocortex of adult mice
Magavi, S. S., Leavitt, B. R., & Macklis, J. D. (2000) · Nature · doi:10.1038/35016083 · Cited by 1,216 · cited 1×
“In addition, all sections were stained with the pan-neuronal marker neuronal nuclei (NeuN) [31] and the DNA stain DAPI that highlights nuclei.”
Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs
Olson, J. K., & Miller, S. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3916 · Cited by 1,215 · cited 1×
“This stimulus is known to induce an acute inflammatory response [36] and shows that our protocol to detect microglia is sensitive to tissue undergoing an immune reaction and that this reaction is limited locally to one hemisphere (Figure 4).”
BackgroundMonosynaptic Restriction of Transsynaptic Tracing from Single, Genetically Targeted Neurons
Wickersham, I. R., Lyon, D. C., Barnard, R. J. O., Mori, T., Finke, S., Conzelmann, K.-K., Young, J. A. T., & Callaway, E. M. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.033 · Cited by 1,187
Cited by
Items 101–200 of 557
Han, Y., Heuermann, R. J., Lyman, K. A., Fisher, D., Ismail, Q.-A., & Chetkovich, D. M. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.99 · Cited by 53
A novel gene editing system to treat both Tay–Sachs and sandhoff diseases
Ou, L., Przybilla, M. J., Tăbăran, A.-F., Overn, P., O’Sullivan, M. G., Jiang, X., Sidhu, R., Kell, P. J., Ory, D. S., & Whitley, C. B. (2020) · Gene Therapy · doi:10.1038/s41434-019-0120-5 · Cited by 52
Genome editing in the mouse brain with minimally immunogenic Cas9 RNPs
Stahl, E. C., Sabo, J. K., Kang, M. H., Allen, R., Applegate, E., Kim, S., Kwon, Y., Seth, A., Lemus, N., Salinas-Rios, V., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.06.019 · Cited by 51
Long-term Cre-mediated retrograde tagging of neurons using a novel recombinant pseudorabies virus
Oyibo, H. K., Znamenskiy, P., Oviedo, H. V., Enquist, L. W., & Zador, A. M. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00086 · Cited by 50
Climbing fibers provide essential instructive signals for associative learning
Silva, N. T., Ramírez, J. E., Pritchett, D. L., & Carey, M. R. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01594-7 · Cited by 55
“Although we had used standard parameters for viral ChR2 expression 28,48,79 and there was no obvious anatomical, physiological or behavioral indication of ChR2 overexpression, we next asked whether lower levels of ChR2 expression in CFs (CF-ChR2-LE; Fig.”
Tackling Glaucoma from within the Brain: An Unfortunate Interplay of BDNF and TrkB
Dekeyster, E., Geeraerts, E., Buyens, T., Van den Haute, C., Baekelandt, V., De Groef, L., Salinas-Navarro, M., & Moons, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142067 · Cited by 49
“Based on the fact that the applicability of different viral vector systems depends on the experimental setup, tissue, and species[46, 47], we first defined the optimal vector system for local delivery to the mouse SC [48].”
Yang, J., Prouvot, P.-H., Reyes‐Puerta, V., Stüttgen, M. C., Stroh, A., & Luhmann, H. J. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx261 · Cited by 49
“Multiple experimental parameters influence the scope of optogenetic network activation: Firstly, AA-virus injections inherently result in varying infection rates per neuron due to multiplicity of infection, leading to heterogeneity of opsin expression (Aschauer et al. 2013), this in turn affecting inhibitory photocurr…”
BackgroundOrefice, N. S., Souchet, B., Braudeau, J., Alves, S., Piguet, F., Collaud, F., Ronzitti, G., Tada, S., Hantraye, P., Mingozzi, F., et al. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2019.06.005 · Cited by 48
Depla, J. A., Sogorb-González, M., Mulder, L. A., Heine, V., Konstantinova, P., van Deventer, S., Wolthers, K., Pajkrt, D., Sridhar, A., & Evers, M. (2020) · Molecular Therapy: Methods & Clinical Development · doi:10.1016/j.omtm.2020.05.028 · Cited by 37
Suppressing Anterior Cingulate Cortex Modulates Default Mode Network and Behavior in Awake Rats
Tu, W., Ma, Z., Ma, Y., Dopfel, D., & Zhang, N. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa227 · Cited by 55
“It is likely that viral vectors transported retrogradely and anterogradely (Aschauer et al. 2013; Castle et al. 2014; Smith et al. 2016).”
BackgroundSaxena, A., Little, J. T., Nedungadi, T. P., & Cunningham, J. T. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00747.2014 · Cited by 48
“Some AAV vectors have been shown to produce retrograde transfection of cells projecting to the injection site (2, 44).”
BackgroundBenskey, M. J., Kuhn, N. C., Galligan, J. J., Garcia, J., Boye, S. E., Hauswirth, W. W., Mueller, C., Boye, S. L., & Manfredsson, F. P. (2015) · Molecular Therapy · doi:10.1038/mt.2015.7 · Cited by 47
Arguello, A. A., Richardson, B. D., Hall, J. L., Wang, R., Hodges, M., Mitchell, M., Stuber, G. D., Rossi, D. J., & Fuchs, R. A. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.157 · Cited by 53
“One caveat is that retrograde transport efficiency in various AAV serotypes appears to vary across species (Aschauer et al, 2013; Rothermel et al, 2013).”
BackgroundRole of Dorsal Striatum Histone Deacetylase 5 in Incubation of Methamphetamine Craving
Li, X., Carreria, M. B., Witonsky, K. R., Zeric, T., Lofaro, O. M., Bossert, J. M., Zhang, J., Surjono, F., Richie, C. T., Harvey, B. K., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.12.008 · Cited by 49
“maximal (37), we collected DS tissue for subsequent immunoblotting assays (see the Supplement and Supplemental Figure S1A).”
MethodChakrabarti, S., Pattison, L. A., Doleschall, B., Rickman, R. H., Blake, H., Callejo, G., Heppenstall, P. A., & Smith, E. S. J. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41314 · Cited by 49
“Modified muscarinic receptor–based designer receptors exclusively activated by designer drugs (DREADDs) is a technology based on this concept, which can increase or decrease neuronal (mostly in the central nervous system [CNS]) firing and which consequently affects a variety of behaviors (9,10), such as enhanced feedi…”
BackgroundHan, Z., Luo, N., Ma, W., Liu, X., Cai, Y., Kou, J., Wang, J., Li, L., Peng, S., Xu, Z., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39554-7 · Cited by 53
Structural and cellular biology of adeno-associated virus attachment and entry
Zengel, J. R., & Carette, J. E. (2020) · Advances in virus research · doi:10.1016/bs.aivir.2020.01.002 · Cited by 54
Zwang, T. J., Sastre, E. D., Wolf, N., Ruiz-Uribe, N., Woost, B., Hoglund, Z., Fan, Z., Bailey, J., Nfor, L., Buée, L., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114574 · Cited by 48
“Prior studies have evaluated the tropism of these capsids for neurons and report that this is an effective system for delivering genes broadly to excitatory neurons 27–29 ; however, this method may not have captured the full spectrum of disease-susceptible neurons.”
BackgroundGerits, A., Vancraeyenest, P., Vreysen, S., Laramée, M., Michiels, A., Gijsbers, R., den Haute, C. V., Moons, L., Debyser, Z., Baekelandt, V., et al. (2015) · Neurophotonics · doi:10.1117/1.nph.2.3.031209 · Cited by 56
Schultz, M. K., Gentzel, R., Usenovic, M., Gretzula, C., Ware, C., Parmentier-Batteur, S., Schachter, J. B., & Zariwala, H. A. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.003 · Cited by 41
Mazuel, L., Blanc, J., Repond, C., Bouchaud, V., Raffard, G., Déglon, N., Bonvento, G., Pellerin, L., & Bouzier-Sore, A.-K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174990 · Cited by 44
Wang, Q., Henry, A. M., Harris, J. A., Oh, S. W., Joines, K. M., Nyhus, J., Hirokawa, K. E., Dee, N., Mortrud, M., Parry, S., et al. (2014) · Journal of Comparative Neurology · doi:10.1002/cne.23567 · Cited by 44
“AAV has been reported to have at least 11 different serotypes, and each of them can infect different tissues or cell types (Aschauer et al., 2013; Wu et al., 2006).”
BackgroundFocused ultrasound gene delivery for the treatment of neurological disorders
Kofoed, R. H., & Aubert, I. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.12.006 · Cited by 46
Dadalko, O. I., Siuta, M., Poe, A., Erreger, K., Matthies, H. J. G., Niswender, K., & Galli, A. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0887-15.2015 · Cited by 47
“Of many naturally available serotypes, rAAV-5 was shown to be the most efficient for genetic transduction in the dorsal striatum of mice (Aschauer et al., 2013) and nonhuman primates (Markakis et al., 2010).”
BackgroundRecombinant Viral Vectors as Neuroscience Tools
Chen, S., Haam, J., Walker, M., Scappini, E., Naughton, J., & Martin, N. P. (2019) · Current Protocols in Neuroscience · doi:10.1002/cpns.67 · Cited by 49
“…+ +++ ++ rh.8 ++ ++ ++ rh.10 +++ ++ + RETRO +++ +++ +++ Relative transduction of AAV serotypes in mouse brain summarized from published studies (Aschauer et al., 2013; Cearley & Wolfe, 2006; Cearley et al., 2008; Tervo et al., 2016). activation in response to stimuli in order to understand how…”
BackgroundCollicular circuits for flexible sensorimotor routing
Duan, C. A., Pagan, M., Piet, A. T., Kopec, C. D., Akrami, A., Riordan, A. J., Erlich, J. C., & Brody, C. D. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00865-x · Cited by 46
Pignataro, D., Sucunza, D., Vanrell, L., Lopez-Franco, E., Dopeso-Reyes, I. G., Vales, A., Hommel, M., Rico, A. J., Lanciego, J. L., & Gonzalez-Aseguinolaza, G. (2017) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2017.00002 · Cited by 42
“In mice, vector transport along astrocytes has been described in previous studies and was found to be serotype dependent (anterograde: AAV2, Salegio et al., 2012; retrograde: AAV5, Aschauer et al., 2013).”
BackgroundMethodInfluentialTranslation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic
Miniarikova, J., Evers, M. M., & Konstantinova, P. S. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.002 · Cited by 49
“Several AAV serotypes showed efficacious transduction of neurons with different tropisms to immune cells of the brain, such as astrocytes, microglia, and oligodendrocytes.(107) Given the brain complexity, the route of administration and subsequent efficient vector genome delivery is one of the critical obstacles in a…”
BackgroundA Retino-retinal Projection Guided by Unc5c Emerged in Species with Retinal Waves
Murcia‐Belmonte, V., Coca, Y., Vegar, C., Negueruela, S., Romero, C. D. J., Valiño, A. J., Sala, S., da Silva, R. V., Kania, A., Borrell, V., et al. (2019) · Current Biology · doi:10.1016/j.cub.2019.02.052 · Cited by 44
“In an attempt to label a larger number of R-R cells, we injected AAV5-RFP viruses [22] into the eye of E13.”
Wang, C., Sun, W., Ling, S., Wang, Y., Wang, X., Meng, H., Li, Y., Yuan, X., Liu, R., Liu, R., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.09.030 · Cited by 42
Campos, L., Arokiaraj, C. M., Chuapoco, M. R., Chen, X., Goeden, N., Gradinaru, V., & Fox, A. S. (2023) · Current Research in Neurobiology · doi:10.1016/j.crneur.2023.100086 · Cited by 44
Advances in the treatment of neuronal ceroid lipofuscinosis
Rosenberg, J. B., Chen, A., Kaminsky, S. M., Crystal, R. G., & Sondhi, D. (2019) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2019.1684258 · Cited by 44
Disentangling neuronal inhibition and inhibitory pathways in the lateral habenula
Webster, J. F., Vroman, R., Balueva, K., Wulff, P., Sakata, S., & Wozny, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-65349-7 · Cited by 42
TRPV1-mediated sonogenetic neuromodulation of motor cortex in freely moving mice
Xu, K., Yang, Y., Hu, Z., Yue, Y., Gong, Y., Cui, J., Culver, J. P., Bruchas, M. R., & Chen, H. (2023) · Journal of Neural Engineering · doi:10.1088/1741-2552/acbba0 · Cited by 42
“88%, respectively, which was consistent with other reported transduction efficiencies (figures 2(d) and (e)) [32, 33].”
ResultSłyk, Ż., Stachowiak, N., & Małecki, M. (2024) · Biomedicines · doi:10.3390/biomedicines12071523 · Cited by 44
Ballon, D., Rosenberg, J. B., Fung, E. K., Nikolopoulou, A., Kothari, P. J., De, B. P., He, B., Chen, A., Heier, L., Sondhi, D., et al. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.116 · Cited by 42
Casado-Sainz, A., Gudmundsen, F., Bærentzen, S. L., Lange, D., Ringsted, A., Tejada, I. M., Medina, S., Lee, H., Svarer, C., Keller, S. H., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01207-y · Cited by 49
“Nigro-striatal dopaminergic stimulation increases exploratory behaviors and lowers self-grooming We targeted dorsal striatal dopaminergic innervations by using TH:Cre rats [18] treated with retrograde neuronal transduction by the AAV6 serotype, as previously established in rats [26], mice [27], and non-human primates…”
MethodRecombinant adeno-associated virus 8 vector in gene therapy: Opportunities and challenges
Zhao, L., Yang, Z., Zheng, M., Shi, L., Gu, M., Liu, G., Miao, F., Chang, Y., Fanghua, H., & Tang, N. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.010 · Cited by 43
“The transgenic expression of rAAV8 in glial cells was significant.(22) Moreover, after intramuscular injection of rAAV8, effective and stable transduction was found in the white matter, dorsal root ganglion neurons, and peripheral nerves of the spinal cord of neonatal mice.”
Navarro-Romero, A., Vázquez‐Oliver, A., Gomis‐González, M., Garzón-Montesinos, C., Falcón‐Moya, R., Pastor, A., Martín‐García, E., Pizarro, N., Busquets-García, A., Revest, J., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.01.014 · Cited by 42
“The AAV9 vector was selected for its good transduction efficiency into the hippocampus (Aschauer et al., 2013).”
Using rAAV2-retro in rhesus macaques: Promise and caveats for circuit manipulation
Cushnie, A. K., El-Nahal, H. G., Bohlen, M. O., May, P. J., Basso, M. A., Grimaldi, P., Wang, M. Z., de Velasco, E. M. F., Sommer, M. A., & Heilbronner, S. R. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108859 · Cited by 41
“Several research groups have reported discrepancies in transport properties of AAVs when the same serotype is used (Aschauer et al., 2013; Burger et al., 2004a; Cearley et al., 2008; Kaspar et al., 2002; Masamizu et al., 2011; Salegio et al., 2013; Zingg et al., 2017).”
BackgroundTransduction patterns in the CNS following various routes of AAV-5-mediated gene delivery
Pietersz, K. L., Martier, R., Baatje, M. S., Liefhebber, J. M. P., Brouwers, C. C., Pouw, S. M., Fokkert, L., Lubelski, J., Petry, H., Martens, G. J. M., et al. (2020) · Gene Therapy · doi:10.1038/s41434-020-0178-0 · Cited by 41
Applications of chemogenetics in non-human primates
Raper, J., & Galván, A. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102204 · Cited by 40
Fadila, S., Beucher, B., Dopeso‐Reyes, I. G., Mavashov, A., Brusel, M., Anderson, K., Ismeurt, C., Goldberg, E. M., Ricobaraza, A., Hernández-Alcoceba, R., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci159316 · Cited by 40
“Moreover, adenovirus vectors lead to transgene expression within hours after injection (58, 59), in contrast to most AAV vectors, which take between 10 and 14 days for expression (75, 76).”
Gallent, E. A., & Steward, O. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.01.005 · Cited by 39
“Different AAV serotypes exhibit differential tropisms (Aschauer et al., 2013; Burger et al., 2004; Taymans et al., 2007), and the AAV-2 serotype used here has been shown to be relatively neuron-specific (Bartlett et al.”
New Neurons in the Post-ischemic and Injured Brain: Migrating or Resident?
Nemirovich-Danchenko, N. M., & Khodanovich, M. Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00588 · Cited by 41
Adotevi, N. K., Lewczuk, E., Sun, H., Joshi, S., Dabrowska, N., Shan, S., Williamson, J., & Kapur, J. (2019) · Annals of Neurology · doi:10.1002/ana.25635 · Cited by 40
“AAV9 viruses have high tropism and transduction efficiency in the hippocampus.(22) We used the Cam kinase promoter to restrict GluA1 deletion to the CA1 pyramidal neurons and other excitatory neurons in the hippocampus.”
MethodTutorial: design and execution of CRISPR in vivo screens
Braun, C. J., Adames, A. C., Saur, D., & Rad, R. (2022) · Nature Protocols · doi:10.1038/s41596-022-00700-y · Cited by 41
Hadaczek, P., Stanek, L., Ciesielska, A., Sudhakar, V., Samaranch, L., Pivirotto, P., Bringas, J., O'Riordan, C., Mastis, B., San Sebastian, W., et al. (2016) · Molecular Therapy - Methods & Clinical Development · doi:10.1038/mtm.2016.37 · Cited by 37
Klaus, F., Paterna, J., Marzorati, E., Sigrist, H., Goetze, L., Schwendener, S., Bergamini, G., Jehli, E., Azzinnari, D., Fuertig, R., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.08.001 · Cited by 41
“cell types was demonstrated, being highest in astrocytes (Aschauer et al., 2013).”
BackgroundMethodResultInfluentialEpilepsy and optogenetics: can seizures be controlled by light?
Tønnesen, J., & Kokaia, M. (2017) · Clinical Science · doi:10.1042/cs20160492 · Cited by 40
Su, W., Kang, J., Sopher, B., Gillespie, J., Aloi, M. S., Odom, G. L., Hopkins, S., Case, A., Wang, D. B., Chamberlain, J. S., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13081 · Cited by 32
Tracking the Time-Dependent Role of the Hippocampus in Memory Recall Using DREADDs
Varela, C., Weiss, S., Meyer, R. M., Halassa, M. M., Biedenkapp, J. C., Wilson, M. A., Goosens, K. A., & Bendor, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154374 · Cited by 46
“Four weeks after surgery, a time point when receptor expression is maximal and stable [18], mice were trained in a contextual fear conditioning protocol.”
BackgroundGene Delivery Strategies to Promote Spinal Cord Repair: Supplementary Issue: Stem Cell Biology
Walthers, C. M., & Seidlits, S. K. (2015) · Biomarker Insights · doi:10.4137/bmi.s20063 · Cited by 37
Adeno‐associated virus‐based Alzheimer's disease mouse models and potential new therapeutic avenues
Ittner, L. M., Klugmann, M., & Ke, Y. D. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14637 · Cited by 39
“Different AAV serotypes have the general ability to transduce all major brain cell types; however, expression levels depend on both promoters and serotypes used (Aschauer et al., 2013).”
BackgroundModeling Pulmonary Disease Pathways Using Recombinant Adeno-Associated Virus 6.2
Strobel, B., Duechs, M. J., Schmid, R., Stierstorfer, B., Bucher, H., Quast, K., Stiller, D., Hildebrandt, T., Mennerich, D., Gantner, F., et al. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0338ma · Cited by 39
Self-citationAdeno-associated virus and lentivirus vectors: a refined toolkit for the central nervous system
Blessing, D., & Déglon, N. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.08.004 · Cited by 42
Ng, R. C.-L., Jian, M., Ma, O. K.-F., Xiang, A. W., Bunting, M., Kwan, J., Wong, C. W.-K., Yick, L.-W., Chung, S. K., Lam, K. S. L., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03066-y · Cited by 39
“The vector spread is also limited despite axonal transport facilitating anatomical AAV distribution [35].”
BackgroundDouble Virus Vector Infection to the Prefrontal Network of the Macaque Brain
Oguchi, M., Okajima, M., Tanaka, S., Koizumi, M., Kikusui, T., Ichihara, N., Kato, S., Kobayashi, K., & Sakagami, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132825 · Cited by 38
“In this study, the adeno-associated viral vector type 5 (AAV5), which has high efficiency of infection to cell bodies of neurons in its injection site [18, 19], was injected into the LPFC.”
Gene suppressing therapy for Pelizaeus-Merzbacher disease using artificial microRNA
Li, H., Okada, H., Suzuki, S., Sakai, K., Izumi, H., Matsushima, Y., Ichinohe, N., Goto, Y., Okada, T., & Inoue, K. (2019) · JCI Insight · doi:10.1172/jci.insight.125052 · Cited by 37
“Optimization using serotypes that have higher tropism for oligodendrocytes such as AAV8 (40) or a synthetic novel capsid, olig001 (42), may further improve safety and cell-specific viral infection of our system.”
BackgroundMethodResultInfluentialHuntington, T. E., & Srinivasan, R. (2021) · Aging and disease · doi:10.14336/ad.2021.0517 · Cited by 34
“In this regard, several AAV serotypes are capable of astrocyte transduction, including AAV 2/1, 2/5, 2/8, and 2/9 [118, 119, 182-185].”
BackgroundParvalbumin Interneurons Shape Neuronal Vulnerability in Blunt TBI
Chandrasekar, A., Heuvel, F. O., Tar, L., Hagenston, A. M., Palmer, A., Linkus, B., Ludolph, A. C., Huber-Lang, M. S., Boeckers, T. M., Bading, H., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy139 · Cited by 35
Komatsu, H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.785703 · Cited by 40
“Among them, AAV9 displays a remarkable ability to transduce not only neurons but also parenchymal brain cells (Manfredsson et al., 2009; Aschauer et al., 2013; Hammond et al., 2017).”
BackgroundFekete, S., Aebischer, M. K., Imiołek, M., Graf, T., Ruppert, R., Lauber, M., D’Atri, V., & Guillarme, D. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117088 · Cited by 34
Mosser, S., Alattia, J., Dimitrov, M. I., Matz, A., Pascual, J., Schneider, B. L., & Fraering, P. C. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu449 · Cited by 36
“(18), AAV9 vectors, when injected in the hippocampus, have a generally broad tropism for many different brain cell types, including oligodendrocytes, microglia, astrocytes and neurons (including inhibitory neurons).”
BackgroundGene Therapy Models of Alzheimer’s Disease and Other Dementias
Combs, B., Kneynsberg, A., & Kanaan, N. M. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-3271-9_25 · Cited by 32
“, neurons, glia, or both) and specific brain regions [89, 90].”
BackgroundBeloate, L. N., Omrani, A., Adan, R. A. H., Webb, I. C., & Coolen, L. M. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0937-16.2016 · Cited by 36
“Importantly,thecross-sensitizingeffectsofsexualexperienceon amphetaminerewardaredependentonaperiodofsexualabsti-nence(Pitchersetal.,2010a,2013),andakeymediatorofthis amphetaminecross-sensitizationismating-induced (cid:2) FosB expression in the NAc (Pitchers et al., 2010b, 2013).”
InfluentialStudies of cortical connectivity using optical circuit mapping methods
Anastasiades, P. G., Marques–Smith, A., & Butt, S. J. B. (2017) · The Journal of Physiology · doi:10.1113/jp273463 · Cited by 32
“The expression efficiency of the virus can vary based on serotype (Aschauer et al. 2013), and will also depend upon the duration of expression, so either the injection volume, viral serotype or survival time post-injection should be adjusted to ensure opsin expression is restricted to the presynaptic structure of inte…”
BackgroundNew era of optogenetics: from the central to peripheral nervous system
Xu, X., Mee, T., & Jia, X. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1726279 · Cited by 32
“Furthermore, AAV serotypes and LV glycoproteins also influence transduction efficiency, tropism and axonal transport in different tissues (Aschauer et al. 2013; Parr-Brownlie et al. 2015).”
BackgroundHironaka, K., Yamazaki, Y., Hirai, Y., Yamamoto, M., Miyake, N., Miyake, K., Okada, T., Morita, A., & Shimada, T. (2015) · Scientific Reports · doi:10.1038/srep13104 · Cited by 33
Optogenetic Approaches for Controlling Seizure Activity
Tung, J. K., Berglund, K., & Gross, R. E. (2016) · Brain stimulation · doi:10.1016/j.brs.2016.06.055 · Cited by 33
La accesibilidad de los portales web de las universidades públicas andaluzas
Balsells, L. A. C., González, J. C. G., Balsells, M. A. C., & Chamorro, V. A. P. (2017) · Revista española de Documentación Científica · doi:10.3989/redc.2017.2.1372 · Cited by 40
Development of an optogenetic toolkit for neural circuit dissection in squirrel monkeys
O’Shea, D. J., Kalanithi, P. S. A., Ferenczi, E., Hsueh, B., Chandrasekaran, C., Goo, W., Diester, I., Ramakrishnan, C., Kaufman, M. T., Ryu, S. I., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24362-7 · Cited by 36
Meng, Y., Sun, D., Qin, Y., Dong, X., Luo, G., & Liu, Y. (2021) · Molecular Therapy: Methods & Clinical Development · doi:10.1016/j.omtm.2021.02.019 · Cited by 20
The neuronal retromer can regulate both neuronal and microglial phenotypes of Alzheimer's disease
Qureshi, Y. H., Berman, D. E., Marsh, S. E., Klein, R. L., Patel, V. M., Simoes, S., Kannan, S., Petsko, G. A., Stevens, B., & Small, S. A. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110262 · Cited by 31
Strategies to improve safety profile of AAV vectors
Suoranta, T., Laham-Karam, N., & Ylä‐Herttuala, S. (2022) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2022.1054069 · Cited by 33
“For example, recent studies have compared the axonal transport and anterograde transneuronal spread of the serotypes, finding differences that could have important implications for safety and clinical trial design (Aschauer et al., 2013; Zingg et al., 2017; YuWai-Man et al., 2020).”
ResultPseudotyped Lentiviral Vectors for Retrograde Gene Delivery into Target Brain Regions
Kobayashi, K., Inoue, K., Tanabe, S., Kato, S., Takada, M., & Kobayashi, K. (2017) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2017.00065 · Cited by 30
“Some serotypes of AAV vectors transfer foreign genes in a retrograde fashion in the central nervous system (Masamizu et al., 2011; Aschauer et al., 2013; Löw et al., 2013; Salegio et al., 2013; San Sebastian et al., 2013).”
BackgroundAndrianova, L., Yanakieva, S., Margetts‐Smith, G., Kohli, S., Brady, E. S., Aggleton, J. P., & Craig, M. T. (2023) · eLife · doi:10.7554/elife.77364 · Cited by 32
Schuette, S. R. M., Fernández‐Fernández, D., Lamla, T., Rosenbrock, H., & Hobson, S. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3600-15.2016 · Cited by 31
“The rAAV5 vectors were produced as described previously (Aschauer et al., 2013).”
MethodBraun, D. J., Kalinin, S., & Feinstein, D. L. (2017) · ASN NEURO · doi:10.1177/1759091417696161 · Cited by 30
“…bacterial Cre recombinase (catalag # AV-9-PV2004) attached to the fluorescent reporter molecule enhanced green fluorescent protein (eGFP) was chosen for its broad tropism, ability to diffuse into a relatively large area, and low-inflammatory induction (Karra and Dahm, 2010; Aschauer et al., 2013).”
BackgroundGenetic targeting of astrocytes to combat neurodegenerative disease
Kirschen, G., Kéry, R., & Chen, A. F. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.265541 · Cited by 30
“In comparison to AAV2/5 serotypes, researchers have demonstrated that AAV2/8 may transduce astrocytes with the higher efficiency in the CNS (Aschauer et al., 2013).”
ResultSano, H., Kobayashi, K., Yoshioka, N., Takebayashi, H., & Nambu, A. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108887 · Cited by 29
Ozawa, A., & Arakawa, H. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113234 · Cited by 32
“However, the transfection of DREADD transgenes appears to require a longer incubation time; 12 h after AAV infusion is not sufficient to detect the fluorescence tags attached to the virus vectors around the injection site (Aschauer et al., 2013).”
BackgroundSelective Manipulation of Neural Circuits
Park, H. G., & Carmel, J. B. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0425-7 · Cited by 32
Moya, E. A., Go, A., Kim, C. B., Fu, Z., Simonson, T. S., & Powell, F. L. (2020) · The Journal of Physiology · doi:10.1113/jp279331 · Cited by 33
“We used the AAV serotype 2, which demonstrates a restricted area of action (Aschauer et al. 2013; Watakabe et al. 2015) and is targeted to infect mainly neurons (Davidson & Breakefield, 2003; Watakabe et al.”
MethodOptogenetic Modulation of TrkB Signaling in the Mouse Brain
Hong, J., & Heo, W. D. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.010 · Cited by 30
Robins, M. T., Chiang, T., Mores, K. L., Alongkronrusmee, D., & van Rijn, R. M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00112 · Cited by 29
“Our viral AAV8DREADD construct was expressed under a human synapsin promoter which specifically targets neurons (59), and given that the majority of the dorsal striatum consists of MSNs and AAV8 has been shown to infect GABAergic neurons in the mouse striatum (60), activation of virally expressed striatal hM4Di recept…”
BackgroundA sensory-motor-sensory circuit underlies antinociception ignited by primary motor cortex in mice
Wang, F., Tian, Z., Ding, H., Yang, X. W., Wang, F., Ji, R.-X., Xu, L., Cao, Z.-X., Ma, S., Zhang, M., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.03.027 · Cited by 30
Ultramicroscopy as a novel tool to unravel the tropism of AAV gene therapy vectors in the brain
Alves, S., Bode, J., Bemelmans, A., Kalle, C. V., Cartier, N., & Tews, B. (2016) · Scientific Reports · doi:10.1038/srep28272 · Cited by 27
Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer’s Disease: Are We There Yet?
Raikwar, S. P., Thangavel, R., Dubova, I., Ahmed, M. E., Selvakumar, G. P., Kempuraj, D., Zaheer, S. A., Iyer, S. S., & Zaheer, A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180422 · Cited by 32
“AAV serotype comparison for CNS transduction [77, 78].”
HCN4 knockdown in dorsal hippocampus promotes anxiety‐like behavior in mice
Günther, A., Luczak, V., Gruteser, N., Abel, T. G., & Baumann, A. (2018) · Genes Brain & Behavior · doi:10.1111/gbb.12550 · Cited by 30
“We employed AAV serotype 9, which provides anterograde and retrograde transport in neurons.(43) A single infusion of eGFP-encoding rAAV resulted in strong expression of the fluorescent marker protein throughout the dorsal hippocampus and remained restricted to hippocampal tissue for several weeks.”
MethodWeber‐Adrian, D., Kofoed, R. H., Silburt, J., Noroozian, Z., Shah, K., Burgess, A., Rideout, S., Kügler, S., Hynynen, K., & Aubert, I. (2021) · Scientific Reports · doi:10.1038/s41598-021-81046-5 · Cited by 30
Ocular Gene Therapy: An Overview of Viral Vectors, Immune Responses, and Future Directions
Banou, L., Sarrafpour, S., Teng, C. C., & Liu, J. (2024) · The Yale Journal of Biology and Medicine · doi:10.59249/hwid7537 · Cited by 30
Gene therapy approaches in the non-human primate model of Parkinson’s disease
Pignataro, D., Sucunza, D., Rico, A. J., Dopeso‐Reyes, I. G., Roda, E., Rodriguez-Perez, A. I., Labandeira-García, J. L., Broccoli, V., Kato, S., Kobayashi, K., et al. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1681-3 · Cited by 30
“…the diffusion of lentiviral vectors if often limited to few millimeters away from the injection site (Linterman et al. 2011), whereas for AAVs the transduced area largely depends on the AAV serotype, production, and purification (Aschauer et al. 2013; Cearley and Wolfe 2006; Ayuso et al. 2010).”
Giorgio, E., Lorenzati, M., Cervo, P. R. D. V., Brussino, A., Cernigoj, M., Sala, E. D., Stella, A. B., Ferrero, M., Caiazzo, M., Capellari, S., et al. (2019) · Brain · doi:10.1093/brain/awz139 · Cited by 27
Sweeney, C. G., Kearney, P. J., Fagan, R. R., Smith, L. A., Bolden, N. C., Zhao-Shea, R., Rivera, I. V., Kolpakova, J., Xie, J., Gao, G., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0457-x · Cited by 26
“This could reflect limited viral spread away from the VTA; however the AAV9 serotype is noted for its widespread infection [33].”
BackgroundThe Influence of Murine Genetic Background in Adeno-Associated Virus Transduction of the Mouse Brain
He, T., Itano, M. S., Earley, L. F., Hall, N. E., Riddick, N., Samulski, R. J., & Li, C. (2019) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2019.030 · Cited by 25
“Although, retrograde trafficking of AAV5 particles has been previously reported.(7) From the current study, we see significantly less contralateral EGFP expression in FVB mice for AAV5, even though it has a similar amount of striatal transduction as in C57 mice.”
BackgroundResultInfluentialGene transfer engineering for astrocyte-specific silencing in the CNS
Mérienne, N., Delzor, A., Viret, A., Dufour, N., Rey, M. J., Hantraye, P., & Déglon, N. (2015) · Gene Therapy · doi:10.1038/gt.2015.54 · Cited by 27
Rimoldi, M., Lucchiari, S., Pagliarani, S., Meola, G., Comi, G. P., & Abati, E. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07826-9 · Cited by 27
“AAV serotype 9 (AAV9), isolated from human liver tissue, was proved to be able to reach the MNs of the spinal cord, the cortical neurons and the deep structures of the brain, due to its unique ability to cross the blood-brain barrier [120 – 123].”
Calcium imaging for analgesic drug discovery
Iseppon, F., Linley, J. E., & Wood, J. N. (2022) · Neurobiology of Pain · doi:10.1016/j.ynpai.2021.100083 · Cited by 29
“the spinal cord, with differences in transduction efficiency and cell types between the serotypes (Aschauer et al., 2013; Burger et al., 2004; Kuhn et al., 2012; Yu et al., 2016).”
Strategies for Targeting Neural Circuits: How to Manipulate Neurons Using Virus Vehicles
Hui, Y., Zheng, X., Zhang, H., Li, F., Yu, G., Li, J., Zhang, J., Gong, X., & Guo, G. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2022.882366 · Cited by 27
Metadata
- Authors
- Aschauer, D. F., Kreuz, S., & Rumpel, S.
- Affiliations
- Research Institute of Molecular Pathology (AT)
- Boehringer Ingelheim (Germany) (DE)
- Corresponding author
- Rumpel, Simon
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-09-27
- Volume
- 8
- Issue
- 9
- Pages
- e76310
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3785459
- OpenAlex
- W2015741711
- Cited by
- 522
- References
- 68
- Citations by year
- 2026: 26 · 2025: 31 · 2024: 47 · 2023: 44 · 2022: 40 · 2021: 49 · 2020: 44 · 2019: 57 · 2018: 45 · 2017: 42 · 2016: 42 · 2015: 34 · 2014: 20 · 2013: 1
- FWCI
- 21.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- adeno-associated virus vectors, AAV serotypes, AAV1, AAV2, AAV5, AAV6, AAV8, AAV9, transduction efficiency, axonal transport, retrograde transport, self-complementary AAV, gene delivery to the brain, striatum, hippocampus, neocortex, astrocytes, cortical neurons, microglia, oligodendrocytes, entorhinal cortex, dentate gyrus, reporter gene expression
- MeSH terms
- Dependovirus, Analysis of Variance, Animals, Axonal Transport, Brain, Cloning, Molecular, Gene Expression Regulation, Genetic Vectors, Microscopy, Fluorescence, Organ Specificity, Transduction, Genetic, Gene Transfer Techniques, Transgenes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.